News

News

TSO3 : ORIGINAL CUSTOMERS UPGRADE TO NEW 3M™ OPTREOZ™ 125-Z STERILIZER

Quebec City, Canada, December 12, 2011 – TSO3 Inc. (“TSO3” or the “Company”) (TSX: TOS) an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, today reported 80% of its initial Canadian customers (125L Ozone Sterilizer users) have agreed to upgrade to the new 3M™ Optreoz™ 125-Z sterilizer by the end of January 2012. These additional 3M sterilizers will be adding to the already installed and revenue generating unit base.

Read more

News

AS REQUIRED, TSX CONDITIONNALY APPROVES THE SHAREHOLDER RIGHTS PLAN

Quebec City, Canada, November 11, 2011 – TSO3 Inc. (“TSO3” or the “Corporation”) (TSX: TOS) an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, announced today that it has been notified by the Toronto Stock Exchange (the “TSX”) that the TSX has conditionally approved for filing the Corporation’s shareholder rights plan (the “Plan”) recently adopted by the Board of Directors of the Corporation (the “Board”), as previously announced by press release on October 25, 2011.

Read more

News

TSO3: Q3 HIGHEST REVENUE GENERATING QUARTER IN COMPANY HISTORY

Quebec City, November 2, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, posted its highest historical quarterly revenues in third quarter of 2011. In Q3 2011, sales of 3M™ Optreoz™ 125-Z Sterilizers, consumable supplies, accessories, service contracts, training, after-sales service, as well as licence revenues, amounted to $1,153,460, compared to $176,397 in Q3 2010. For the nine-month period ended September 30, 2011, revenues amounted to $2,046,014 compared to $910,275 for the same period in 2010. The difference is explained by higher sales of private labelled 3M™ Optreoz™ Sterilizers, accessories and consumables, as a result of initial and growing 3M™ commercial activity on the Company’s products.

Read more

News

TSO3 ADOPTS SHAREHOLDER RIGHTS PLAN

Quebec City, Canada, October 25, 2011 – TSO3 Inc. (“TSO3” or the “Corporation”) (TSX: TOS) an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, announced today that the Board of Directors of the Corporation has adopted a shareholder rights plan agreement (the “Plan”) designed to foster fair treatment of all shareholders in connection with any potential take-over bid for TSO3. The Plan has been adopted as a result of the current softness in the Corporation’s share price due to general market conditions, which could lead to unsolicited offers at unfavorable conditions. While the Plan becomes effective immediately, it requires shareholder ratification within six months of its adoption. TSO3 will seek shareholder ratification of the Plan at the next annual shareholder Meeting scheduled to be held on April 25, 2012. If the Plan is not ratified as such by the shareholders, it will be void and of no further force and effect. A summary of the principal terms of the Plan will be described in the management proxy circular to be sent to all shareholders prior to the meeting.

Read more

News

TSO3 to hold Q3 2011 Financial Results Conference Call

Quebec City, October 25, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) announced today that it will report Financial Results for the third quarter of 2011, for the period ending September 30 2011, on Wednesday, November 2, 2011. TSO3 will host a Conference Call and a Webcast at 10:30 A.M. (ET) the same day to discuss financial results and to update on recent activities.

Read more